THREE NEW ONCOLOGY BIOSIMILARS INTRODUCED IN US MARKETS

Highlights:

• Bevacizumab-bvzr, rituximab-pvvr, and Trastuzumab-qyyp have been introduced in the United States.
• Pfizer will become the first manufacturer to launch 3 oncology biosimilar products in the US market.
• The 3 antibodies will be available at discounted prices as compared to their brand name equivalents.

Pfizer has introduced three new oncology biosimilar treatmen....